Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis

Clinical Chemistry

Volumn 55, Issue 10, 2009, Pages 1886-1888

  Vermeersch, Pieter ^a   Blockmans, Daniel ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANALYTIC METHOD; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE; LETTER; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SMALL VESSEL VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIKELIHOOD FUNCTIONS; MYELOBLASTIN; PEROXIDASE; VASCULITIS;

EID: 70349673315     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.130583     Document Type: Letter

References (4)

1. Csernok E, Lamprecht P, Gross WL. Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol 2006;2:174-175
2. Radice A, Sinico RA. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005;38:93-103.
3. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000;57:846-862 (Pubitemid 30434775)
4. Vermeersch P, Vervaeke S, Blockmans D, van Hoovels L, Marien G, Vanmaele H, Bossuyt X. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: comparative analysis of different strategies. Clin Chim Acta 2008;397:77-81.